1
Exhibit 10.60
EXECUTION COPY
CTI - VALORIA OPTION AGREEMENT
This Agreement (the "Agreement"), is made as of this 10th day of July,
1996 by and among CytoTherapeutics, Inc., a Delaware corporation ("CTI") and
Societe Financiere Valoria S.A., a Swiss corporation ("Valoria").
WHEREAS, each of CTI and Valoria owns that number of shares of Common
Stock ("Common Stock") of Modex Therapeutiques, S.A. ("Modex") set forth next to
its name on Exhibit A acquired on foundation of Modex; and
WHEREAS, simultaneously herewith Valoria has loaned SFr 2.4 million to
Modex pursuant to a Convertible Loan Agreement (the "Original Valoria Loan") and
has agreed, under such Agreement, to loan an additional SFr 1.2 million to Modex
on the second anniversary date (the "Second Anniversary") of this Agreement (the
"Second Valoria Loan," together with the Original Valoria Loan, the "Valoria
Loans"); and
WHEREAS, simultaneously herewith CTI has invested SFr 1.2 million to
subscribe for 1,000 additional shares of Common Stock, has loaned SFr 1.2
million to Modex pursuant to a Convertible Loan Agreement and has agreed, under
such Agreement, to loan Modex an additional SFr 2.4 million on the Second
Anniversary (together with the first Loan, the "CTI Loans"), if certain
conditions are met; and
WHEREAS, it was a mutual condition to CTI and Valoria making such
investments in Modex simultaneously herewith that each enter into this
Agreement; and
WHEREAS, CTI wishes to arrange for an option to acquire the shares of
Common Stock held by Valoria and the Valoria Loans, and Valoria wishes to grant
to CTI such an option, on the terms and conditions contained herein; and
WHEREAS, Valoria wishes to obtain an option to require CTI to purchase
the shares of Common Stock held by Valoria and the Valoria Loans and CTI is
willing to grant such an option, under the terms and conditions contained
herein;
NOW, THEREFORE, in consideration of the mutual covenants herein
contained and other valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, CTI and Valoria hereby agree as follows:
2
1. Restrictions on Transfer.
(a) Valoria Shares and Notes. None of the shares of Common Stock
acquired by Valoria on the formation of Modex or the shares of Common Stock to
be acquired by Valoria upon conversion of the Valoria Loans (collectively, the
"Valoria Shares") or the Valoria Loans (together with the Valoria Shares, the
"Valoria Securities") or any interest therein may be sold, exchanged, signed,
transferred, pledged, hypothecated or otherwise encumbered or disposed of, at
any time prior to the expiration of this Agreement except pursuant to the
exercise by Valoria of the Valoria Exchange Option, or the exercise by CTI of
the CTI Exchange Option (in each case, as defined below).
(b) Certificates to be Held by Notary. The Valoria Shares shall be held
by a notary (the "Notary") acceptable to CTI and Valoria under the terms of an
Escrow Agreement acceptable to CTI, Valoria and the Notary until the earlier of
the termination of this Agreement or such time as such Valoria Shares shall have
been exchanged in accordance with the provisions hereof. Any new, additional or
different securities which Valoria may be entitled to receive by virtue of the
conversion of the Valoria Loans or any stock dividend, stock split, reverse
stock split, recapitalization, reorganization, merger, consolidation, split-up
or other similar change shall be held by such Notary and subject to the same
restrictions, terms and conditions as set forth herein. Valoria shall possess
all incidents of ownership of the Valoria Shares, including the right to receive
or reinvest dividends with respect to the Valoria Shares and to vote such
Valoria Shares (subject to the terms of any other agreements applicable
thereto), except that Valoria shall not be entitled to possession of the Valoria
Shares until the restrictions provided for in this Agreement have lapsed.
2. Exchange Option for Valoria Securities.
(a) CTI Exchange Option. CTI shall have the option (the "CTI Exchange
Option") to purchase the Valoria Securities on the following terms and
conditions:
(i) During First Two Years. At any time prior to the
Second Anniversary, CTI may purchase all but not less
than all of the Valoria Securities for the greater of
(i) Sfr 3.6 million or (ii) Sfr 2.4 million plus
simple interest thereon at the rate of 30% per year
from the Closing Date until the Option Closing Date
(as defined below), accruing daily, such
consideration to be payable in cash or, at CTI's
option, in whole or in part in shares of Common Stock
of CTI, par value $.01 per share ("CTI Common
Stock"), valued as described below.
(ii) After First Two Years. At any time on or after the
Second Anniversary, CTI may purchase all but not less
than all of the Valoria Securities at a price equal
to 110% of the As Converted Value of the Valoria
Securities as of the Option Notice Date (as such
terms are defined below), such consideration to be
payable in cash or, at CTI's
-2-
3
option, in whole or in part, in shares of CTI Common
Stock, valued as described below.
(b) CTI Option Notice. CTI shall notify Valoria of its exercise of the
CTI Exchange Option in writing (the "CTI Option Notice") and shall indicate in
such notice whether CTI intends to purchase such shares with cash or with CTI
Common Stock or with cash and CTI Common Stock.
If the CTI Exchange Option is being exercised pursuant to Section
2(a)(i), CTI shall pay to Valoria (in cash or CTI Common Stock) the aggregate
purchase price as indicated in Section 2(a)(i) within 30 days of the date of the
CTI Option Notice (the "Notice Date") against simultaneous release to CTI by the
Notary of all escrowed Valoria Shares and assignment to CTI of all of Valoria's
interest (if any) in the Valoria Loans.
If the CTI Exchange Option is being exercised pursuant to Section
2(a)(ii), CTI and Valoria shall have 30 days from Notice Date to agree upon the
fair market value of the Valoria Securities determined on the basis of the fair
market value of the shares of Modex Common Stock that would be held by Valoria
assuming the conversion of all outstanding Valoria Loans into shares of Modex
Common Stock and the similar conversion of all outstanding CTI Loans into shares
of such Common Stock (the "As Converted Value"). If, by the end of such
thirty-day period, no agreement as to the As Converted Value has been reached,
the As Converted Value shall be determined by an appraisal. All appraisals shall
be undertaken by an independent investment banking firm (initially agreed to be
Xxxxxxxxx & Xxxxx) acceptable to both CTI and Valoria (the "Appraiser")
commencing on the 31st day after the Notice Date. On such date, Valoria and CTI
shall each submit to the Appraiser a final estimate of the As Converted Value,
and, within 60 days of such submission, the Appraiser shall determine which of
such two estimates is closer to the As Converted Value as determined by the
Appraiser and such closer estimate shall be deemed to be the As Converted Value.
Within 30 days after the determination of the As Converted Value specified
above, CTI shall pay Valoria the aggregate purchase price (in cash or CTI Common
Stock) as indicated in Section 2(a)(ii) (the date of such payment pursuant to
this sentence or pursuant to the last sentence in the previous paragraph being
referred to herein as the "Option Closing Date") against simultaneous release to
CTI by the Notary of all escrowed Valoria Shares and assignment to CTI of all of
Valoria's interest (if any) in the Valoria Loans. The party whose final estimate
is not selected as the As Converted Value shall pay the cost of the appraisal.
(c) Valoria Exchange Option. If at any time on or after the Second
Anniversary and prior to the tenth anniversary of this Agreement (the "Tenth
Anniversary"), no Public Market exists for the Founder's Shares, Valoria shall
have the option (the "Valoria Exchange Option") to require CTI to purchase all
but not less than all of the Valoria Securities at a price equal to 90% of the
As Converted Value as of the Put Notice Date (as defined below), such
consideration to be payable in cash or, at CTI's option, in whole or in part in
shares of CTI Common Stock, valued as described below. A "Public Market" for the
Founder's
-3-
4
Shares will exist if and only if the shares of CTI and Valoria Common Stock are
listed for trading on an internationally recognized securities market.
(d) Valoria Put Notice. Valoria shall notify CTI of its exercise of the
Valoria Exchange Option in writing (the "Put Notice"). CTI shall indicate in a
notice delivered to Valoria within 30 days of the date of such Put Notice (the
"Notice Date") whether CTI intends to purchase such shares with cash or with CTI
Common Stock or with cash and CTI Common Stock. CTI and Valoria shall have 30
days from the Notice Date to agree upon the As Converted Value. If, by the end
of such thirty-day period, no agreement as to the As Converted Value has been
reached, the As Converted Value shall be determined by an appraisal, as provided
in Section 2(b) above, the cost of which shall be paid as provided therein.
Within 30 days after the determination of the As Converted Value, CTI shall pay
to Valoria the aggregate purchase price (in cash or CTI Common Stock) indicated
in Section 4(c) (the date of such payment being referred to herein as the "Put
Closing Date").
(e) Valuation of CTI Common Stock. For purposes of this Section 2, the
fair market value of CTI Common Stock shall be the average of the closing prices
(as described below) for shares of the CTI Common Stock for each of the 10
consecutive trading days before and each of the 10 consecutive trading days
after the Put Notice Date or the Option Notice Date, as the case may be. The
closing price for such shares for each day shall be the average of the reported
closing bid and asked prices on the principal United States securities exchange
registered under the Securities Exchange Act of 1934, as amended, on which such
shares are listed or admitted to trading, or if they are not listed or admitted
to trading on any such exchange, the average of the quoted closing bid and asked
prices as reported on the Nasdaq Stock Market, or any comparable system, or if
such shares are not quoted on the Nasdaq Stock Market, or any comparable system,
the average of the closing bid and asked prices as furnished by any market maker
in such shares who is a member of the National Association of Securities
Dealers, Inc.
(f) Price Protection for Valoria. In the event that CTI sells,
transfers, assigns or otherwise disposes any Valoria Securities acquired by CTI
from Valoria pursuant to Section 2(a) (or any shares of Modex Common Stock
issuable on conversion of any such securities) within 180 days of the Option
Closing Date and the price CTI receives for such securities (the "Third Party
Price") is in excess of the price received for such Securities by Valoria from
CTI on the Option Closing Date (the "Xxxxxxx Xxxxx"), then CTI shall pay to
Valoria the difference between the Third Party Price and the Xxxxxxx Xxxxx with
respect to all such securities so sold, transferred, assigned or otherwise
disposed of by CTI, such consideration to be payable in cash or, at CTI's
option, in whole or in part in shares of CTI Common Stock, valued at the Option
Closing Date as described above.
3. Representations, Warranties and Agreements.
Valoria hereby acknowledges, represents and warrants to, and agrees
with, CTI as follows:
-4-
5
(a) Valoria understands that the shares of CTI Common Stock
that Valoria may receive hereunder have not been registered under the U.S.
Securities Act of 1933, as amended (the "Securities Act"), or any state or
foreign securities laws and are expected to be issued in reliance upon
Regulation S promulgated under the Securities Act;
(b) Valoria has been supplied with or has had sufficient
access to all other information, including financial statements and other
financial information of CTI, to which a reasonable investor would attach
significance in making investment decisions, and has had the opportunity to ask
questions and receive answers from knowledgeable individuals concerning CTI, so
that, as a reasonable investor, Valoria has been able to make his own
independent decision to put himself in a position wherein he may be acquiring
such CTI Common Stock;
(c) Valoria is not a U.S. Person and is not entering into this
Agreement in order to acquire any CTI Common Stock for the account or benefit of
a U.S. Person. For purposes of this Agreement, "U.S. Person" shall have the
meaning set forth in Rule 903(o) of Regulation S under the Securities Act;
(d) Valoria agrees not to offer or sell such CTI Common Stock
in the United States or to or for the account or benefit of a U.S. Person or
citizen of the United States prior to the expiration of the forty (40) day
period commencing on the date Valoria receives any such CTI Common Stock
hereunder (the "Restricted Period"). Valoria acknowledges that CTI will not
authorize any transfer or sale of such CTI Common Stock in the United States or
to a U.S. Person or citizen of the United States other than in accordance with
Regulation S and U.S. federal securities laws. Prior to any sale or transfer of
such CTI Common Stock during the Restricted Period or in the United States or to
a U.S. Person, CTI may require the written opinion of United States legal
counsel addressed to CTI, as to whether such transfer or sale is in compliance
with the Securities Act and the rules and regulations applicable thereunder,
including Regulation S, and may require certification of the transferor and the
transferee of such CTI Common Stock as to such compliance; and
(e) Should Regulation S not be available with regard to any
exercise of the Valoria Exchange Option or the CTI Exchange Option (for example,
because Valoria is or has become a U.S. Person), Valoria and CTI acknowledge and
agree that the Shares of CTI Common Stock to be issued in exchange for Xxxxxxx'x
Xxxxxxx Securities hereunder shall be issued in a private placement exempt from
the registration requirements of the Securities Act pursuant to Section 4.2 of
such Act and that any shares of CTI Common Stock so issued shall be subject to
the restrictions generally applicable to such securities in transactions which
qualify for such exemption.
4. Legend.
Each certificate representing the CTI Common Stock issued hereunder
pursuant to Regulation S shall bear a restrictive legend in substantially the
form set forth below:
-5-
6
"The securities represented by this certificate have not been
registered under the U.S. Securities Act of 1933, as amended
(the "Act"), and have been issued pursuant to an exemption
from registration pursuant to Regulation S under the Act.
These shares cannot be transferred, offered, or sold in the
United States or to a U.S. Person (as that term is defined in
Regulation S) unless such shares are registered under the Act
or an exemption from registration is available. The offer or
sale of these shares to a U.S. Person (as that term is defined
in Regulation S) or in the United States is subject to certain
restrictions as set forth in that certain Option Agreement
dated July __, 1996 between CTI and the original holders of
these shares."
Shares of CTI Common Stock, if any, issued in a private placement pursuant to
Section 3(e) shall also bear an appropriate restrictive legend.
5. Termination.
(a) This Agreement shall terminate on the earlier to occur of the tenth
anniversary of this Agreement or the closing of an underwritten public offering
of Modex Common Stock.
6. Notices. All notices and other communications hereunder shall be in
writing and shall be deemed to have been received when delivered to CTI and
Valoria at their respective addresses set forth on Exhibit A, or in any case to
such other address as the addressee shall have furnished to the other party
hereto in the manner prescribed by this Section.
7. Specific Performance. The rights of the parties under this Agreement
are unique and, accordingly, each party shall, in addition to such other
remedies as may be available to it at law, have the right to enforce its rights
hereunder by actions for specific performance to the extent permitted by law.
8. Entire Agreement. This Agreement constitutes the entire agreement
among the parties with respect to the subject matter hereof and supersedes and
cancels all prior agreements and understandings between them as to such subject
matter.
9. Waivers and Further Agreements. Neither this Agreement nor any
provision hereof may be waived, modified, terminated or amended except by a
written agreement signed by CTI and Valoria. Any waiver by either party of a
breach of any provision of this Agreement shall not operate or be construed as a
waiver of any subsequent breach of that provision or of any other provision
hereof. Each of the parties hereto agrees to execute all such further
instruments and documents and to take all such further action as any other party
may reasonably require in order to effectuate the terms and purposes of this
Agreement.
10. Assignment; Successors and Assigns. This Agreement shall be binding
upon and shall inure to the benefit of the parties hereto and their respective
heirs, executors, legal representatives, successors and permitted assigns.
Without limiting the general application of
-6-
7
the foregoing sentence, more particularly, while this Agreement does not
contemplate the transfer of any Valoria Securities or any interest therein
except through the exercise by CTI of the CTI Exchange Option or the exercise by
Valoria of the Valoria Exchange Option, should any such other transfer occur by
agreement of the parties or by operation of law, the transferee shall, to the
maximum extent permitted by law, be bound by the terms of this Agreement and any
applicable provisions of the Articles of Incorporation of Modex.
11. Counterparts. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instruments.
12. Section Headings. The headings contained in this Agreement are for
reference purposes only and shall not in any way affect the meaning or
interpretation of this Agreement.
13. Choice of Law. This Agreement shall be governed and construed
according to the internal laws of Switzerland.
14. Dispute Resolution. All disputes, differences, controversies or
claims arising in connection with, or questions occurring under, this Agreement
shall be settled as provided in Exhibit B, except for the determination of As
Converted Value, which shall be conclusively determined as provided for in
Section 2.
-7-
8
IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed
as of the date first above written.
CYTOTHERAPEUTICS, INC.
By/s/ Xxxx X. Xxxxxxx
----------------------------------
Title: Chief Executive Officer
SOCIETE FINANCIERE VALORIA S.A.
By/s/ Xxxxxxxxx Xxxx
----------------------------------
Title: Power of Attorney
-8-
9
EXHIBIT A - STOCKHOLDERS AGREEMENT
Original Shares Shares Acquired
--------------- Simultaneously
Herewith
--------
CTI 6,500 1,000
Valoria 500 --
10
EXHIBIT B
Arbitration
Any and all disputes, controversies or claims arising out of, involving or
relating to the existence, validity, performance, amendment, breach or
termination of this Agreement shall be referred to, settled and finally resolved
exclusively under the rules of arbitration of La Chambre de Commerce et
d'Industrie de Geneve ("CCIG") by an arbitral tribunal appointed as set forth
herein in accordance with said rules. To the extent not prohibited under
applicable law, the arbitral tribunal's decision shall be final and binding on
the parties and, to the extent not prohibited under applicable law, the parties
hereby exclude any right of appeal to any court on the merits of any dispute.
Subject to the provisions of the last paragraph, each party shall nominate one
arbitrator. If a party fails to nominate an arbitrator within thirty (30) days
from the date when the claimant's request for arbitration has been communicated
to the other party, such appointment shall be made by the rules of CCIG. The two
arbitrators so appointed shall agree upon the third arbitrator who shall act as
Chair of the arbitral tribunal. If said two arbitrators fail to nominate a Chair
within thirty (30) days from the latter of the two appointments, the Chair shall
be selected by the rules of CCIG. Such appointment shall be final and binding
upon the parties.
The place of arbitration shall be Geneva, Switzerland.
The language to be used in the arbitral proceeding shall be English.
The proceedings shall be governed by the provisions of Chapter 12 of the Swiss
Federal Act on International Private Law of December 18, 1987 relating to
international arbitration and the rules of arbitration of CCIG.
This Agreement and the arbitral award shall be governed by the law of
Switzerland. The award shall be in writing and shall include the arbitral
tribunal's decision as to the costs of the arbitration and reasonable legal
fees. The award may grant any relief appropriate under the applicable law,
including without limitation declaratory relief and/or specific performance. The
award will be notified to the parties by the Arbitral Tribunal.
In the event that disputes arise between two parties under this Agreement and
any other agreement, document or instrument executed in connection with the
transactions contemplated hereby, such disputes shall be resolved in a
consolidated arbitral proceeding by the three arbitrators appointed in
accordance with the provisions above. Notwithstanding the foregoing, in the
event that disputes arise between more than two parties under this Agreement or
under this Agreement and any other agreement, document or instrument
-10-
11
executed in connection with the transactions contemplated hereby, such disputes
shall be resolved in a consolidated arbitral proceeding by a single arbitrator
appointed in accordance with the rules of CCIG.
-11-
